<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Int J Clin Exp Pathol</journal-id>
<journal-id journal-id-type="iso-abbrev">Int J Clin Exp Pathol</journal-id>
<journal-id journal-id-type="publisher-id">ijcep</journal-id>
<journal-title-group>
<journal-title>International Journal of Clinical and Experimental Pathology</journal-title>
</journal-title-group>
<issn pub-type="epub">1936-2625</issn>
<publisher>
<publisher-name>e-Century Publishing Corporation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31938158</article-id>
<article-id pub-id-type="pmc">6958030</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>High expression of SLC6A10P contributes to poor prognosis in lung adenocarcinoma</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yuan</surname>
<given-names>Kai</given-names>
</name>
<xref ref-type="aff" rid="au1">1</xref>
<xref ref-type="aff" rid="au2">2</xref>
<xref ref-type="author-notes" rid="fn1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gao</surname>
<given-names>Zhao-Jia</given-names>
</name>
<xref ref-type="aff" rid="au1">1</xref>
<xref ref-type="aff" rid="au2">2</xref>
<xref ref-type="author-notes" rid="fn1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yuan</surname>
<given-names>Wei-Dong</given-names>
</name>
<xref ref-type="aff" rid="au1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yuan</surname>
<given-names>Jun-Qiang</given-names>
</name>
<xref ref-type="aff" rid="au1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Yong</given-names>
</name>
<xref ref-type="aff" rid="au1">1</xref>
</contrib>
<aff id="au1">
<label>1</label>
<institution>Division of Thoracic Surgery, The Affiliated Changzhou No. 2 People’s Hospital of Nanjing Medical University</institution>
<addr-line>Changzhou, Jiangsu Province, China</addr-line>
</aff>
<aff id="au2">
<label>2</label>
<institution>Heart and Lung Disease Laboratory, The Affiliated Changzhou No. 2 People’s Hospital of Nanjing Medical University</institution>
<addr-line>Changzhou, Jiangsu Province, China</addr-line>
</aff>
</contrib-group>
<author-notes>
<corresp><bold>Address correspondence to:</bold> Dr. Yong Wang, Division of Thoracic Surgery, The Affiliated Changzhou No. 2 People’s Hospital of Nanjing Medical University, 29 Xinglong Lane, Changzhou 213003, Jiangsu Province, China. Tel: +86 519 88123833; Fax: +86 0519 88123833; E-mail: <email>doctor_wang1960@163.com</email></corresp>
<fn id="fn1">
<label>*</label>
<p>Equal contributors.</p>
</fn>
</author-notes>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>01</day>
<month>2</month>
<year>2018</year>
</pub-date>
<volume>11</volume>
<issue>2</issue>
<fpage>720</fpage>
<lpage>726</lpage>
<history>
<date date-type="received">
<day>08</day>
<month>12</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>12</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>IJCEP Copyright © 2018</copyright-statement>
<copyright-year>2018</copyright-year>
</permissions>
<abstract>
<p>Purpose: To investigate the expression profile and prognostic value of SLC6A10P in patients with non-small cell lung cancer (NSCLC). Patients and methods: TCGA datasets were used to investigate the differential expression of SLC6A10P in NSCLC, lung adenocarcinoma (LUAD), and lung squamous cell carcinoma (LUSC). Expression of SLC6A10P was measured by in situ hybridization in tissue microarrays containing 136 NSCLC (51 LUAD and 85 LUSC) patients. The prognostic value of SLC6A10P was then evaluated. Results: SLC6A10P was highly expressed in tumor tissues compared with normal lung tissues. High SLC6A10P expression was associated with lymph node metastasis (NSCLC, P = 0.0054; LUAD, P = 0.0149), more advanced tumor stage (NSCLC, P = 0.0126; LUAD, P = 0.0416) and poor overall survival (NSCLC, P = 0.0248; LUAD, P = 0.0316) in NSCLC and LUAD. Multivariate analysis revealed that SLC6A10P was an independent prognostic factor in LUAD patients (P = 0.017). SLC6A10P showed no association with clinicopathological parameters and no prognostic value in LUSC. Conclusion: SLC6A10P is highly expressed in tumor tissues and its high expression predictspoor survival in patients with LUAD. SLC6A10P might serve as a novel therapeutic target and prognostic biomarker in LUAD patients in the future.</p>
</abstract>
<kwd-group>
<kwd>SLC6A10P</kwd>
<kwd>lung adenocarcinoma</kwd>
<kwd>pseudogene</kwd>
<kwd>prognosis</kwd>
<kwd>bioinformatics</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>